Polycystic ovary syndrome as a paradigm for prehypertension, prediabetes, and preobesity.
about
Polycystic ovary syndrome: clinical implication in perimenopausePhysical Properties of Blood Are Altered in Young and Lean Women with Polycystic Ovary SyndromeAssociation of IL-1β, IL-1Ra and FABP1 gene polymorphisms with the metabolic features of polycystic ovary syndrome.Metabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.Meta-inflammation and cardiometabolic disease in obesity: Can heat therapy help?Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters.
P2860
Polycystic ovary syndrome as a paradigm for prehypertension, prediabetes, and preobesity.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Polycystic ovary syndrome as a paradigm for prehypertension, prediabetes, and preobesity.
@en
type
label
Polycystic ovary syndrome as a paradigm for prehypertension, prediabetes, and preobesity.
@en
prefLabel
Polycystic ovary syndrome as a paradigm for prehypertension, prediabetes, and preobesity.
@en
P2860
P1476
Polycystic ovary syndrome as a paradigm for prehypertension, prediabetes, and preobesity.
@en
P2093
Héctor F Escobar-Morreale
Manuel Luque-Ramírez
P2860
P2888
P356
10.1007/S11906-014-0500-6
P577
2014-12-01T00:00:00Z
P6179
1038819897